Refractive Change Induced by 2.8-mm Corneal Incision

NCT ID: NCT00742950

Last Updated: 2011-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-08-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators' purpose is to study the induced refractive change caused by different 2.8-mm corneal incision locations in phacoemulsification, because the investigators hypothesize that the effect may be different for nasal, temporal, and superior location, although they are considered astigmatism neutral.

Patients will be randomized to nasal or temporal incision, or assigned to superior incision, depending on preexisting astigmatism. Visual acuity, refraction, keratometry, Pentacam analysis, intraocular pressure, biomicroscopy, and funduscopy, will be carried out before and after phacoemulsification.

Outcome measures will be induced corneal refractive change (Fourier power vector analysis), ISV change, and visual acuity, at 6 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract Refractive Surgery Astigmatism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

I

Nasal 2.8-mm corneal incision

Group Type ACTIVE_COMPARATOR

Nasal 2.8-mm corneal incision

Intervention Type PROCEDURE

Phacoemulsification through a nasal 2.8-mm incision

II

Temporal 2.8-mm corneal incision

Group Type ACTIVE_COMPARATOR

Temporal 2.8-mm corneal incision

Intervention Type PROCEDURE

Phacoemulsification through a 2.8-mm temporal incision

III

Superior 2.8-mm corneal incision

Group Type ACTIVE_COMPARATOR

Superior 2.8-mm incision

Intervention Type PROCEDURE

Phacoemulsification through a superior 2.8-mm corneal incision

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nasal 2.8-mm corneal incision

Phacoemulsification through a nasal 2.8-mm incision

Intervention Type PROCEDURE

Temporal 2.8-mm corneal incision

Phacoemulsification through a 2.8-mm temporal incision

Intervention Type PROCEDURE

Superior 2.8-mm incision

Phacoemulsification through a superior 2.8-mm corneal incision

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Phacoemulsification nasal incision Phacoemulsification temporal incision Phacoemulsification superior incision

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Visual impairment for daily tasks caused by cataract
* Age older than 50 years
* Steep axis of corneal astigmatism at 90° ± 20° or 180° ± 20°
* Ability to cooperate in the protocol procedures

Exclusion Criteria

* Age below 50
* Inability to cooperate with measurements
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Universitario Ramon y Cajal

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hospital Ramón y Cajal

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jaime Tejedor, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Dept Ophthalmology

José A Pérez-Rodríguez, MD

Role: STUDY_CHAIR

Dept Ophthalmology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept Ophthalmology, Hospital Universitario Ramón y Cajal

Madrid, Madrid, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Tejedor J, Murube J. Choosing the location of corneal incision based on preexisting astigmatism in phacoemulsification. Am J Ophthalmol. 2005 May;139(5):767-76. doi: 10.1016/j.ajo.2004.12.057.

Reference Type BACKGROUND
PMID: 15860279 (View on PubMed)

Tejedor J, Perez-Rodriguez JA. Astigmatic change induced by 2.8-mm corneal incisions for cataract surgery. Invest Ophthalmol Vis Sci. 2009 Mar;50(3):989-94. doi: 10.1167/iovs.08-2778. Epub 2008 Nov 14.

Reference Type DERIVED
PMID: 19011013 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CINPHACO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.